Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00453115 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Gemcitabine

Sponsor

National Cancer Center, Korea